✦ LIBER ✦

Health-related quality-of-life analysis from the TRINOVA-1 study of weekly paclitaxel plus trebananib or placebo in women with recurrent ovarian cancer

✍ Scribed by Raspagliesi, F.; Lhommé, C.; Monk, B.J.; Coleman, R.L.; Herzog, T.J.; Navale, L.; Warner, D.J.; Fujiwara, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of CA-125 response in the TRI

✍ Herzog, T.J.; Richardson, G.E.; Monk, B.J.; Karlan, B.Y.; Marth, C.; Navale, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Health-related quality of life associate

✍ Monk, B.J.; Huang, H.; Penson, R.T.; Davidson, S.A.; Pearl, M.L.; O'Malley, D.M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB